van Iersel, L, Mulder, R L, Denzer, C, Cohen, L E, Spoudeas, H A, Meacham, L R, Sugden, E, Schouten-van Meeteren, A Y N, Hoving, E W, Packer, R J, Armstrong, G T, Mostoufi-Moab, S, Stades, A M, van Vuurden, D, Janssens, G O, Thomas-Teinturier, C C, Murray, R D, di Iorgi, N, Neggers, S J C M M, Thompson, J, Toogood, A A, Gleeson, H, Follin, C, Bardi, E, Torno, L, Patterson, B, Morsellino, V, Sommer, G, Clement, S C, Srivastava, D, Kiserud, C E, Fernandez, A, Scheinemann, K, Raman, S, Yuen, K C J, Wallace, W H, Constine, L S, Skinner, R, Hudson, M M, Kremer, L C M, Chemaitilly, W & van Santen, H M 2022, ' Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors ', Endocrine Reviews, vol. 43, no. 5, pp. 794-823 . https://doi.org/10.1210/endrev/bnab040 Endocrine Reviews, 43(5), 794-823. The Endocrine Society Endocrine reviews, 43(5), 794-823. The Endocrine Society
BMJ Open, 12 van Kalsbeek, R J, Korevaar, J C, Rijken, M, Haupt, R, Muraca, M, Kepák, T, Kepakova, K, Blondeel, A, Boes, S, Frederiksen, L E, Essiaf, S, Winther, J F, Hermens, R P M G, Kienesberger, A, Loonen, J J, Michel, G, Mulder, R L, O'Brien, K B, van der Pal, H J H, Pluijm, S M F, Roser, K, Skinner, R, Renard, M, Uyttebroeck, A, Follin, C, Hjorth, L & Kremer, L C M 2022, ' Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries : the PanCareFollowUp Care prospective cohort study protocol ', BMJ Open, vol. 12, no. 11, e063134 . https://doi.org/10.1136/bmjopen-2022-063134 BMJ open, 12(11):e063134. BMJ Publishing Group BMJ Open, 12, 11
de Baat, E C, van Dalen, E C, Mulder, R L, Hudson, M M, Ehrhardt, M J, Engels, F K, Feijen, E A M, Grotenhuis, H B, Leerink, J M, Kapusta, L, Kaspers, G J L, Merkx, R, Mertens, L, Skinner, R, Tissing, W J E, de Vathaire, F, Nathan, P C, Kremer, L C M, Mavinkurve-Groothuis, A M C & Armenian, S 2022, ' Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines : recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group ', The Lancet Child and Adolescent Health, vol. 6, no. 12, pp. 885-894 . https://doi.org/10.1016/S2352-4642(22)00239-5 The Lancet Child & Adolescent Health, 6, 885-894 The Lancet Child & Adolescent Health, 6, 12, pp. 885-894
The Cochrane Library Mulder, R L, Bresters, D, van den Hof, M, Koot, B G P, Castellino, S M, Loke, Y K K, Post, P N, Postma, A, Sznyi, L S P, Levitt, G A, Bardi, E, Skinner, R & van Dalen, E C 2019, ' Hepatic late adverse effects after antineoplastic treatment for childhood cancer ', Cochrane Database of Systematic Reviews, vol. 2019, no. 4, CD008205 . https://doi.org/10.1002/14651858.CD008205.pub3